Mumbai-based pharmaceutical major major Lupin on Friday said it has received a report from the US Food and Drug Administration (FDA) regarding the closure of inspection of its Mandideep and Aurangabad facilities. With the completion of the inspection, all observations made by the USFDA stand addressed and the facilities are now compliant with its regulations, it added. 